The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. PharmaCyte Biotech Inc shares valued at $33,316 were purchased by Silverman Joshua on Jan 07 ’26. At $0.83 per share, Silverman Joshua acquired 40,000 shares. The insider’s holdings grew to 416,250 shares worth approximately $0.35 million following the completion of this transaction.
Also, Silverman Joshua purchased 30,000 shares, netting a total of over 23,667 in proceeds. Following the buying of shares at $0.79 each, the insider now holds 376,250 shares.
Before that, Silverman Joshua had added 30,000 shares to its account. In a trade valued at $23,493, the CEO and President bought PharmaCyte Biotech Inc shares for $0.78 each. Upon closing the transaction, the insider’s holdings increased to 30,000 shares, worth approximately $0.29 million.
Analyzing PMCB Stock Performance
On last trading session, PharmaCyte Biotech Inc [NASDAQ: PMCB] rose 7.51% to $0.83. The stock’s lowest price that day was $0.772, but it reached a high of $0.8632 in the same session. During the last five days, there has been a surge of approximately 15.28%. Over the course of the year, PharmaCyte Biotech Inc shares have dropped approximately -49.39%. Shares of the company reached a 52-week high of $0.8690 on 01/07/26 and a 52-week low of $0.7000 on 01/02/26.
Support And Resistance Levels for PharmaCyte Biotech Inc (PMCB)
According to the 24-hour chart, there is a support level at 0.7783, which, if violated, would cause prices to drop to 0.7267. In the upper region, resistance lies at 0.8753. The next price resistance is at 0.9207. RSI (Relative Strength Index) is 50.24 on the 14-day chart, showing neutral technical sentiment.
Is PharmaCyte Biotech Inc subject to short interest?
Stocks of PharmaCyte Biotech Inc saw a sharp rise in short interest on 2025-12-15 jumping by 0.17 million shares to 0.64 million. Data from Yahoo Finance shows that the short interest on 2025-11-14 was 0.47 million shares. A jump of 26.19% in short interest reflects a negative sentiment towards the stock. Despite the fact that short shares comprise just 0.06 of the overall float, the days-to-cover ratio (short ratio) jumped to 0.06.
